January 27, 2022 (Miami, FL) — StemExpress had the great privilege to catch up with the editorial team with The Video Journal of Regenerative Medicine while at the 2022 Advanced Therapies Week in Miami, FL.
Our CEO and Founder, Cate Dyer, had the opportunity to discuss the role of StemExpress in supporting the rush of companies entering the cell and gene therapy space. Cate’s discussion focused on the importance of creating a closed-loop system for cell and gene clinical therapies by leveraging existing partnerships with hospital systems and the 8 U.S.-based StemExpress clinical collection centers within nearby proximity to industry-leading hospital systems. The mission of this new approach to the wave of new CGT therapies, accelerating the speed of patient access to these life-changing cell and gene therapies.
Cate also discusses the methods of mitigating the issues surrounding the implementation of autologous therapies for patients across the globe, further accelerating the available toolkit of therapeutic defense strategies for doctors around the globe.
For more information about partnering with StemExpress to accelerate the commercialization and implementation of your cell and gene therapy, submit our contact form.
All press requests, including booking requests for CEO and Founder, Cate Dyer, should be directed to press@stemexpress.com.
Overcoming issues associated with autologous therapies
Collaborating with hospitals and industry in cell therapies
Visit the Video Journal of Regenerative Medicine Online:
